# EDGAR Filing Document

**Accession Number:** 0001782594
**File Stem:** 0001341004-23-000073
**Filing Date:** 2023-2
**Character Count:** 12470
**Document Hash:** e6cde93feb3a97dfe6ce9e46815bd025
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001341004-23-000073.hdr.sgml**: 20230214

**ACCESSION NUMBER**: 0001341004-23-000073

**CONFORMED SUBMISSION TYPE**: SC 13G/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230214

**DATE AS OF CHANGE**: 20230214

**GROUP MEMBERS**: FHP HOLDINGS LTD

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Genetron Holdings Ltd
- **CENTRAL INDEX KEY:** 0001782594
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MEDICAL LABORATORIES [8071]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 13G/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-92048
- **FILM NUMBER:** 23629070

**BUSINESS ADDRESS:**
- **STREET 1:** 1-2/F, BUILDING 11, ZONE 1
- **STREET 2:** NO.8 LIFE SCIENCE PARKWAY
- **CITY:** CHANGPING DISTRICT, BEIJING
- **STATE:** F4
- **ZIP:** 102206
- **BUSINESS PHONE:** 86 (10) 5090 7500

**MAIL ADDRESS:**
- **STREET 1:** 1-2/F, BUILDING 11, ZONE 1
- **STREET 2:** NO.8 LIFE SCIENCE PARKWAY
- **CITY:** CHANGPING DISTRICT, BEIJING
- **STATE:** F4
- **ZIP:** 102206
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Wang Sizhen
- **CENTRAL INDEX KEY:** 0001845547

**FILING VALUES:**
- **FORM TYPE:** SC 13G/A

**MAIL ADDRESS:**
- **STREET 1:** 1-2/F, BUILDING 11, ZONE 1, NO.8
- **STREET 2:** LIFE SCIENCE PARKWAY CHANGPING DISTRICT
- **CITY:** BEIJING
- **STATE:** F4
- **ZIP:** 102206

### UNITED STATES

#### SECURITIES AND EXCHANGE COMMISSION

#### Washington, D.C. 20549

_______________________<br>

### SCHEDULE 13G/A

#### Under the Securities Exchange Act of 1934

#### (Amendment No.2)\*

---

| |
|:---|
| **Genetron Holdings Limited** |
| (Name of Issuer) |
| Ordinary shares, par value US$0.00002 per share |
| (Title of Class of Securities) |
| **37186H100\*\*** |
| (CUSIP Number) |
| **December 31, 2022** |
| (Date of Event which Requires Filing of this Statement) |

---

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

<br> ☐ Rule 13d-1(b)

<br> ☐ Rule 13d-1(c)

<br> ☒ Rule 13d-1(d)

\* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

\*\* There is no CUSIP number assigned to the ordinary shares. CUSIP number 37186H100 has been assigned to the American depositary shares ("ADSs") of the Issuer, which are quoted on NASDAQ Stock Market under the symbol "GTH." Each ADS represents five ordinary shares, par value US$0.00002 per share.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

------

CUSIP No. 37186H100

1. Names of Reporting Persons <br>
 Sizhen Wang

2. Check the Appropriate Box if a Member of a Group (a) ☐

(b) ☐

3. SEC Use Only

4. Citizenship or Place of Organization People's Republic of China

---

| | |
|:---|:---|
| Number of Shares Beneficially Owned by Each Reporting Person With | 5. |
| Number of Shares Beneficially Owned by Each Reporting Person With | 6.<br> Shared Voting Power<br> 4,339,500 ordinary shares<sup>(2)</sup> |
| Number of Shares Beneficially Owned by Each Reporting Person With | 7.<br> Sole Dispositive Power<br> 31,117,620 ordinary shares<sup>(3)</sup> |
| Number of Shares Beneficially Owned by Each Reporting Person With | 8.<br> Shared Dispositive Power<br> 4,339,500 ordinary shares<sup>(2)</sup> |

---

9. Aggregate Amount Beneficially Owned by Each Reporting Person 100,114,120 ordinary shares

10. Check Box if the Aggregate Amount in Row (9) Excludes<br>
 Certain Shares&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ☐

11. Percent of Class Represented by Amount in Row (9) 21.87%<sup>(4)</sup>

12. Type of Reporting Person IN

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) Represents (i) 5,814,480 ordinary shares and 5,000,000 ordinary shares in the form of ADSs held by FHP Holdings Limited, a limited liability company incorporated under the laws of British Virgin Islands wholly owned by Mr. Sizhen Wang, (ii) 11,313,140 ordinary shares in the form of ADSs held by Mr. Sizhen Wang, (iii) 8,990,000 ordinary shares in the form of ADSs held by Alliance Trust Company, Trustee of Super E Growth Trust, where Mr. Sizhen Wang is the settlor, and (iv) 64,657,000 ordinary shares collectively held by FHP acting-in-concert group, consisting of (a) 33,153,000 ordinary shares held by Mr. Hai Yan and (b) a total of 31,504,000 ordinary shares directly held by the FHP-Acting-in-Concert Group (as defined below).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) Represents total of 4,339,500 ordinary shares held by Genetron Discovery Holdings Limited as a record holder, which Mr. Sizhen Wang owns approximately 50.8% equity interests.

On November 19, 2019, FHP Holdings Limited, Mr. Hai Yan, Mr. Weiwu He, Mr. Kevin Ying Hong, Genetron Alliance Holdings Limited and ETP BioHealth II Fund, L.P. entered into a concert party agreement (Mr. Weiwu He, Mr. Kevin Ying Hong, Genetron Alliance Holdings Limited and ETP BioHealth II Fund, L.P., collectively, the "FHP-Acting-in-Concert Group"), pursuant to which the parties agree to (i) always be acting in concert in respect of their respective direct or indirect voting rights at the Issuer's shareholders' general meetings and the Issuer's board meetings, (ii) recognize the controlling position of FHP Holdings Limited; and (iii) act in concert in accordance with FHP Holdings Limited's opinions in respect of the daily operations and management and the major decision-making of the Issuer.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) Represents (i) 5,814,480 ordinary shares and 5,000,000 ordinary shares in the form of ADSs held by FHP Holdings Limited, a limited liability company incorporated under the laws of British Virgin Islands wholly owned by Mr. Sizhen Wang, (ii) 11,313,140 ordinary shares in the form of ADSs held by Mr. Sizhen Wang, and (iii) 8,990,000 ordinary shares in the form of ADSs held by Alliance Trust Company, Trustee of Super E Growth Trust, where Mr. Sizhen Wang is the settlor.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) Calculated based on 457,743,530 ordinary shares issued and outstanding as of December 31, 2022 as provided by the Issuer.

------

CUSIP No. 37186H100

1. Names of Reporting Persons <br>
 FHP Holdings Limited

2. Check the Appropriate Box if a Member of a Group (a) ☐

(b) ☐

3. SEC Use Only

4. Citizenship or Place of Organization British Virgin Islands

---

| | | |
|:---|:---|:---|
| Number of Shares Beneficially Owned by Each Reporting Person With | 5. | Sole Voting Power<br> 75,471,480 ordinary shares<sup>(1)</sup> |
| Number of Shares Beneficially Owned by Each Reporting Person With | 6. | Shared Voting Power<br> 0 ordinary shares |
| Number of Shares Beneficially Owned by Each Reporting Person With | 7. | Sole Dispositive Power<br> 10,814,480 ordinary shares<sup>(2)</sup> |
| Number of Shares Beneficially Owned by Each Reporting Person With | 8. | Shared Dispositive Power<br> 0 ordinary shares |

---

9. Aggregate Amount Beneficially Owned by Each Reporting Person 75,471,480 ordinary shares

10. Check Box if the Aggregate Amount In Row (9) Excludes<br>
 Certain Shares&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ☐ <br>

11. Percent of Class Represented By Amount in Row (9) 16.49%<sup>(3)</sup>

12. Type of Reporting Person CO

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) Represents (i) 5,814,480 ordinary shares and 5,000,000 ordinary shares in the form of ADSs held by FHP Holdings Limited, a limited liability company incorporated under the laws of British Virgin Islands company and (ii) 64,657,000 ordinary shares collectively held by FHP acting-in-concert group, consisting of (a) 33,153,000 ordinary shares held by Mr. Hai Yan and (b) a total of 31,504,000 ordinary shares directly held by the FHP-Acting-in-Concert Group.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) Represents 5,814,480 ordinary shares and 5,000,000 ordinary shares in the form of ADSs held by FHP Holdings Limited, a limited liability company incorporated under the laws of British Virgin Islands wholly owned by Mr. Sizhen Wang.

On November 19, 2019, FHP Holdings Limited, Mr. Hai Yan, Mr. Weiwu He, Mr. Kevin Ying Hong, Genetron Alliance Holdings Limited and ETP BioHealth II Fund, L.P. entered into a concert party agreement, pursuant to which the parties agree to (i) always be acting in concert in respect of their respective direct or indirect voting rights at the Issuer's shareholders' general meetings and the Issuer's board meetings, (ii) recognize the controlling position of FHP Holdings Limited; and (iii) act in concert in accordance with FHP Holdings Limited's opinions in respect of the daily operations and management and the major decision-making of the Issuer.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) Calculated based on 457,743,530 ordinary shares issued and outstanding as of December 31, 2022 as provided by the Issuer.

------

---

| | |
|:---|:---|
| **Item 1(a).** | **Name of Issuer:** |

---

Genetron Holdings Limited (the "Issuer")

---

| | |
|:---|:---|
| **Item 1(b).** | **Address of Issuer's Principal Executive Offices:** |

---

1-2/F, Building 11, Zone 1, No.8 Life Science Parkway Changping District, Beijing, 102206 People's Republic of China

---

| | |
|:---|:---|
| **Item 2(a).** | **Name of Person Filing:** |

---

Sizhen Wang

FHP Holdings Limited

(collectively, the "Reporting Persons")

---

| | |
|:---|:---|
| **Item 2(b).** | **Address of Principal Business Office or, if none, Residence:** |

---

Sizhen Wang

1-2/F, Building 11, Zone 1, No.8 Life Science Parkway Changping District, Beijing, 102206 People's Republic of China

FHP Holdings Limited

Craigmuir Chambers, P.O. Box 71, Road Town, Tortola, VG 1110, British Virgin Islands

---

| | |
|:---|:---|
| **Item 2(c).** | **Citizenship:** |

---

Sizhen Wang: People's Republic of China

FHP Holdings Limited: British Virgin Islands

---

| | |
|:---|:---|
| **Item 2(d).** | **Title of Class of Securities:** |

---

Ordinary shares, par value US$0.00002 per share

---

| | |
|:---|:---|
| **Item 2(e).** | **CUSIP Number:** |

---

CUSIP number 37186H100 has been assigned to the American depositary shares ("ADSs") of the Issuer, each ADS represent five ordinary shares, par value US$0.00002 per share.

**Item 3.** **If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c):**<br>

Not applicable.

**Item 4.** **Ownership.**<br>

The information required by Items 4(a) - (c) is set forth in Rows 5 - 11 of the cover page for each Reporting Person and is incorporated herein by reference.

**Item 5.** **Ownership of Five Percent or Less of a Class.**<br>

Not applicable.

**Item 6.** **Ownership of More than Five Percent on Behalf of Another Person.**<br>

Not applicable.

**Item 7.** **Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.**<br>

Not applicable.

------

**Item 8.** **Identification and Classification of Members of the Group.**<br>

Not applicable.

**Item 9.** **Notice of Dissolution of Group.**<br>

Not applicable.

**Item 10.** **Certifications.**<br>

Not applicable.

------

#### SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 14, 2023

---

| | |
|:---|:---|
| Sizhen Wang | Sizhen Wang |
| By: | /s/ Sizhen Wang |
|  | Name: Sizhen Wang |
| FHP Holdings Limited | FHP Holdings Limited |
| By: | /s/ Sizhen Wang |
|  | Name: Sizhen Wang |
|  | Title: Director |

---

------

#### LIST OF EXHIBITS

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 1\* | [Joint Filing Agreement by and between the Reporting Persons, dated as of February 12, 2021](https://www.sec.gov/Archives/edgar/data/1782594/000095010321002253/dp146099_ex01.htm) |
| \* | Previously Filed |

---

<br>